Active Health Podcast with Dr. Josh Mason
GLP-1 medications have taken the world by storm. But what actually happens in your body when you take them? In this episode of the Active Health Podcast, Dr. Josh Mason and functional medicine coach Kim Mason break down the science behind GLP-1, GLP-2, and the newer triple agonist peptides, and why these medications are only part of the bigger picture when it comes to long-term metabolic health and weight loss. You have likely heard the brand names like semaglutide, tirzepatide, and retatrutide circulating online. These medications work by mimicking glucagon-like peptides in the body, influencing appetite signals, blood sugar regulation, and energy metabolism. But while these medications can be powerful tools, they are not a replacement for lifestyle. In this conversation, we cover: • The differences between GLP-1, GLP-2, and triple agonist peptides • How these medications influence appetite, blood sugar, and metabolism • Why many people experience “food noise” reduction on these medications • Common side effects like nausea and digestive issues • Why some people lose muscle mass during rapid weight loss • The role of protein, resistance training, hydration, and sleep • Why GLP medications should be viewed as a tool, not a solution At Active Health, our philosophy is simple: medications can help, but lifestyle still wins. GLP medications can create a powerful window for change, but long-term success comes from building sustainable habits that improve metabolic health. If you are curious about how these medications actually work, and how to use them responsibly as part of a comprehensive health strategy, this episode will help clarify the science and the misconceptions.
31 episodes
Comments
0Be the first to comment
Sign up now and become a member of the Active Health Podcast with Dr. Josh Mason community!